J.V. Pozadzides

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

Joe Y. Chang, Steven H. Lin, Wenli Dong et al. · The Lancet · 2023 · 224 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Hydrochlorothiazide and cutaneous T cell lymphoma

Richard R. Jahan‐Tigh, Auris Huen, Grace L. Lee et al. · Cancer · 2012 · 68 citations · Full text

Medicine, Hematology, Oncology +11

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Kaiwen Wang, Robyn Du, Nathaniel J. Myall et al. · Journal of Thoracic Oncology · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Bingnan Zhang, Komal Shah, Kaiwen Wang et al. · Journal of Thoracic Oncology · 2025 · 16 citations · Full text

Medicine, Neurology, Oncology +12

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations

Kelsey Pan, Jennifer Owens, Yasir Y. Elamin et al. · Journal of Thoracic Oncology · 2024 · 15 citations · Full text

Medicine, Molecular Genetics, Oncology +17